CoChat

Growth Hormone Improves Cardiopulmonary Capacity and Body Composition in Children With Growth Hormone Deficiency

Capalbo, Donatella, Barbieri, Flavia, Improda, Nicola, Giallauria, Francesco, Di Pietro, Elisa, Rapacciuolo, Antonio, Di Mase, Raffaella, Vigorito, Carlo, Salerno, Mariacarolina · 2017 · The Journal of Clinical Endocrinology & Metabolism
Cited by 24

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Context: Growth hormone deficiency (GHD) in children may be associated with early cardiovascular risk factors and alterations in left ventricular (LV) structure and function; data on cardiopulmonary functional capacity are lacking. Objectives: Aim of the study was to evaluate the effect of GHD and growth hormone (GH) therapy on cardiopulmonary functional capacity, left and right cardiac structure and function, and body composition in children and adolescents. Design: Prospective, case-control study. Patients and Methods: Twenty-one untrained GHD children (11.3 ± 0.8 years) underwent cardiopulmonary exercise testing, echocardiography and dual-energy x-ray absorptiometry, before and after 12 months of GH therapy. Twenty-one controls matched for sex, pubertal status, body mass index, and physical activity (PA) were evaluated at baseline and after 1 year. Results: At baseline, GHD patients showed reduced LV mass (LVM; 63.32 ± 7.80 vs 80.44 ± 26.29 g/m2, P = 0.006), peak oxygen consumption (VO2peak; 22.92 ± 4.80 vs 27.48 ± 6.71 mL/Kg/min, P = 0.02), peak workload (80.62 ± 29.32 vs 103.76 ± 36.20 W, P = 0.02), and O2 pulse (4.93 ± 1.30 vs 7.67 ± 2.93 mL/beat, P = 0.0003), compared with controls. GHD patients also exhibited lower lean body mass (LBM 65.36 ± 7.84% vs 76.13 ± 8.23%, P < 0.001), and higher fat mass (FM 30.84 ± 7.92% vs 22.19 ± 8.18%, P = 0.001) than controls. GH therapy resulted in a significant increase of LVM (72.01 ± 15.88, P = 0.03), VO2peak (26.80 ± 4.97; P = 0.01), peak workload (103.67 ± 32.24, P = 0.001), O2 pulse (6.64 ± 1.68, P = 0.0007), and LBM (75.36 ± 7.59%, P = 0.0001), with a reduction in FM (22.62 ± 7.73%, P = 0.001). No difference was found in either left or right ventricular function. Conclusion: Our results suggest that cardiac structure, body composition and cardiopulmonary functional capacity are impaired in children with untreated GHD and can be restored after short-term GH replacement therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jc.2017-00871

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 36

  1. 2016, Growth hormone (GH) enhances anaerobic capacity: impact on physical function and quality of life in adults with GH deficiency, Clin Endocrinol (Oxf), 85, 660, 10.1111/cen.13147 · DOI
  2. 2008, The effect of growth hormone replacement on exercise capacity in patients with GH deficiency: a metaanalysis, J Clin Endocrinol Metab, 93, 4413, 10.1210/jc.2008-1239 · DOI · Paper page
  3. 2009, Impact of GH substitution on exercise capacity and muscle strength in GH-deficient adults: a meta-analysis of blinded, placebo-controlled trials, Clin Endocrinol (Oxf), 71, 860, 10.1111/j.1365-2265.2009.03592.x · DOI
  4. 2012, Update on early cardiovascular and metabolic risk factors in children and adolescents affected with growth hormone deficiency, Minerva Endocrinol, 37, 379
  5. 2002, Long-term effects of growth hormone therapy on bone mineral density, body composition, and serum lipid levels in growth hormone deficient children: a 6-year follow-up study, Horm Res, 58, 207
  6. 2013, The association between growth response to growth hormone and baseline body composition of children with growth hormone deficiency, Growth Horm IGF Res, 23, 196, 10.1016/j.ghir.2013.07.001 · DOI
  7. 2014, Cluster of cardiometabolic risk factors in children with GH deficiency: a prospective, case-control study, Clin Endocrinol (Oxf), 80, 856, 10.1111/cen.12393 · DOI
  8. 2007, Metabolic parameters and adipokine profile during GH replacement therapy in children with GH deficiency, Eur J Endocrinol, 156, 353, 10.1530/eje.1.02343 · DOI · Paper page
  9. 2014, Circulating asymmetric dimethylarginine and lipid profile in pre-pubertal children with growth hormone deficiency: effect of 12-month growth hormone replacement therapy, Growth Horm IGF Res, 24, 216, 10.1016/j.ghir.2014.08.001 · DOI
  10. 2006, Improvement of cardiac performance and cardiovascular risk factors in children with GH deficiency after two years of GH replacement therapy: an observational, open, prospective, case-control study, J Clin Endocrinol Metab, 91, 1288, 10.1210/jc.2005-0981 · DOI · Paper page
  11. 2004, Left ventricular mass and function in children with GH deficiency before and during 12 months GH replacement therapy, Clin Endocrinol (Oxf), 60, 630, 10.1111/j.1365-2265.2004.02026.x · DOI
  12. 2009, Subtle alterations of cardiac performance in children with growth hormone deficiency: results of a two-year prospective, case-control study, J Clin Endocrinol Metab, 94, 3347, 10.1210/jc.2008-2639 · DOI · Paper page
  13. 2013, Assessment and prognostic relevance of right ventricular contractile reserve in patients with severe pulmonary hypertension, Circulation, 128, 2005, 10.1161/CIRCULATIONAHA.113.001573 · DOI · Paper page
  14. 2014, An imbalance between protective and detrimental molecular pathways is associated with right ventricular dysfunction in congenital heart diseases with outflow obstruction, Int J Cardiol, 172, e519, 10.1016/j.ijcard.2014.01.077 · doi:10.1016/j.ijcard.2014.01.077
  15. Growth Hormone Research Society, 2000, Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society, J Clin Endocrinol Metab, 85, 3990
  16. 2006, The International Physical Activity Questionnaire (IPAQ): a study of concurrent and construct validity, Public Health Nutr, 9, 755, 10.1079/PHN2005898 · DOI · Paper page
  17. 2002, Italian cross-sectional growth charts for height, weight and BMI (6–20 y), Eur J Clin Nutr, 56, 171, 10.1038/sj.ejcn.1601314 · DOI · Paper page
  18. 1987, Principles of Exercise Testing and Interpretation
  19. 2007, Cardiopulmonary exercise testing and its application, Heart, 93, 1285
  20. 2008, Physical fitness in childhood and adolescence: a powerful marker of health, Int J Obes, 32, 1, 10.1038/sj.ijo.0803774 · DOI · Paper page
  21. 2011, Lack of physical activity in young children is related to higher composite risk factor score for cardiovascular disease, Acta Paediatr, 100, 717, 10.1111/j.1651-2227.2011.02226.x · DOI
  22. 2000, Continuation of growth hormone (GH) replacement in GH-deficient patients during transition from childhood to adulthood: a two-year placebo-controlled study, J Clin Endocrinol Metab, 85, 1874, 10.1210/jcem.85.5.6598 · doi:10.1210/jcem.85.5.6598 · Paper page
  23. 2006, The influence of growth hormone status on physical impairments, functional limitations, and health-related quality of life in adults, Endocr Rev, 27, 287, 10.1210/er.2004-0022 · DOI · Paper page
  24. 1991, Growth hormone treatment in growth hormone-deficient adults. II. Effects on exercise performance, J Appl Physiol (1985), 70, 695, 10.1152/jappl.1991.70.2.695 · DOI · Paper page
  25. 1992, Growth hormone treatment of adults with growth hormone deficiency: results of a 13-month placebo controlled cross-over study, Clin Endocrinol (Oxf), 36, 45, 10.1111/j.1365-2265.1992.tb02901.x · DOI · Paper page
  26. 1995, Effect of growth hormone (hGH) replacement therapy on physical work capacity and cardiac and pulmonary function in patients with hGH deficiency acquired in adulthood, J Clin Endocrinol Metab, 80, 552
  27. 2008, Growth hormone replacement therapy in adults with growth hormone deficiency improves maximal oxygen consumption independently of dosing regimen or physical activity, J Clin Endocrinol Metab, 93, 125, 10.1210/jc.2007-1430 · DOI · Paper page
  28. 1998, Exercise capacity and hormonal response in adults with childhood onset growth hormone deficiency during long-term somatropin treatment, Growth Horm IGF Res, 8, 377, 10.1016/S1096-6374(98)80307-9 · DOI
  29. 2007, The growth hormone/insulin-like growth factor-I axis in exercise and sport, Endocr Rev, 28, 603, 10.1210/er.2006-0052 · DOI · Paper page
  30. 1997, Cardiovascular responses to treadmill and cycle ergometer exercise in children and adults, J Appl Physiol (1985), 83, 948, 10.1152/jappl.1997.83.3.948 · DOI · Paper page
  31. 2001, Treadmill and cycle ergometry testing in 5- to 6-year-old children, Eur J Appl Physiol, 85, 472, 10.1007/s004210100461 · DOI
  32. 2016, Muscle and skeletal health in children and adolescents with GH deficiency, Best Pract Res Clin Endocrinol Metab, 30, 771, 10.1016/j.beem.2016.11.012 · DOI
  33. 2001, Alterations in body composition and fat distribution in growth hormone-deficient prepubertal children during growth hormone therapy, Metabolism, 50, 537, 10.1053/meta.2001.22510 · DOI
  34. 2005, Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency, Bone, 37, 642, 10.1016/j.bone.2005.06.012 · DOI
  35. 2016, Long-term effects of growth hormone (GH) replacement therapy on hematopoiesis in a large cohort of children with GH deficiency, Endocrine, 53, 192, 10.1007/s12020-015-0781-9 · DOI
  36. 2009, The physiology of growth hormone and sport, Growth Horm IGF Res, 19, 308, 10.1016/j.ghir.2009.04.023 · DOI

Cited by

See all 24

Metadata

Authors
Capalbo, D., Barbieri, F., Improda, N., Giallauria, F., Di Pietro, E., Rapacciuolo, A., Di Mase, R., Vigorito, C., & Salerno, M.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2017-08-29
Volume
102
Issue
11
Pages
4080-4088
ISSN
  • 0021-972X
  • 1945-7197
Cited by
24
References
3
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.